Verona Pharma PLC (VRNA)
15.69
-0.06
(-0.38%)
USD |
NASDAQ |
May 03, 16:00
15.70
+0.01
(+0.06%)
After-Hours: 20:00
Verona Pharma Price to Book Value: 5.087 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 5.087 |
May 02, 2024 | 5.106 |
May 01, 2024 | 4.934 |
April 30, 2024 | 5.009 |
April 29, 2024 | 5.044 |
April 26, 2024 | 5.015 |
April 25, 2024 | 4.963 |
April 24, 2024 | 4.941 |
April 23, 2024 | 5.054 |
April 22, 2024 | 5.096 |
April 19, 2024 | 5.096 |
April 18, 2024 | 5.220 |
April 17, 2024 | 5.317 |
April 16, 2024 | 5.252 |
April 15, 2024 | 5.122 |
April 12, 2024 | 5.158 |
April 11, 2024 | 5.242 |
April 10, 2024 | 5.275 |
April 09, 2024 | 5.339 |
April 08, 2024 | 5.472 |
April 05, 2024 | 5.518 |
April 04, 2024 | 5.362 |
April 03, 2024 | 5.262 |
April 02, 2024 | 5.164 |
April 01, 2024 | 5.203 |
Date | Value |
---|---|
March 28, 2024 | 5.216 |
March 27, 2024 | 5.349 |
March 26, 2024 | 5.232 |
March 25, 2024 | 5.093 |
March 22, 2024 | 5.210 |
March 21, 2024 | 5.171 |
March 20, 2024 | 5.164 |
March 19, 2024 | 4.960 |
March 18, 2024 | 5.035 |
March 15, 2024 | 5.074 |
March 14, 2024 | 5.038 |
March 13, 2024 | 5.411 |
March 12, 2024 | 5.343 |
March 11, 2024 | 5.158 |
March 08, 2024 | 5.262 |
March 07, 2024 | 5.424 |
March 06, 2024 | 5.453 |
March 05, 2024 | 5.498 |
March 04, 2024 | 5.602 |
March 01, 2024 | 5.897 |
February 29, 2024 | 5.583 |
February 28, 2024 | 5.596 |
February 27, 2024 | 5.806 |
February 26, 2024 | 5.716 |
February 23, 2024 | 5.346 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6654
Minimum
Mar 18 2020
21.24
Maximum
Jul 22 2020
3.792
Average
2.418
Median
Jun 06 2022
Price to Book Value Benchmarks
Biodexa Pharmaceuticals Plc | 0.8683 |
NuCana PLC | 0.446 |
TC BioPharm (Holdings) PLC | 1.364 |
Adaptimmune Therapeutics PLC | 7.434 |
Autolus Therapeutics PLC | 9.995 |
Price to Book Value Related Metrics
Price | 15.69 |
Earnings Yield | -4.59% |
Market Cap | 1.268B |